Abstract

To compare the cost per ‘imaging complete resection’ (ICR) with Gleolan (aminolevulinic acid HCl) oral solution (also known as 5-ALA) guided surgery in conjunction with blue light vs. conventional white light surgery in high grade glioma patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Depression in patients with high-grade glioma: results of the Glioma Outcomes Project.
Frederick Anderson ... Edward R Laws
Neurosurgery | VOL. 54
Frederick Anderson, et. al.Frederick Anderson ... Edward R Laws
01 Feb 2004
Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review.
Jan Coburger ... Christian Rainer Wirtz
Journal of Neuro-Oncology | VOL. 141
Jan Coburger, et. al.Jan Coburger ... Christian Rainer Wirtz
28 Nov 2018
Tailored Intraoperative MRI Strategies in High-Grade Glioma Surgery: A Machine Learning-Based Radiomics Model Highlights Selective Benefits.
Andreas Gruber ... Wolfgang Thomae
Operative neurosurgery (Hagerstown, Md.) | VOL. 26
Andreas Gruber, et. al.Andreas Gruber ... Wolfgang Thomae
22 Dec 2023
Application of intraoperative ultrasound in the resection of high-grade gliomas
Renjie Wei ... Yuxiang Cai
Frontiers in neurology | VOL. 14
Renjie Wei, et. al.Renjie Wei ... Yuxiang Cai
26 Oct 2023
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers